Journey Medical (DERM) Finished Goods (2020 - 2021)

Journey Medical (DERM) reported Finished Goods of $4.3 million for Q4 2021, up 205.56% on a YoY basis from $1.4 million in Q4 2020, and down 30.37% quarter-over-quarter from $6.2 million in Q3 2021.

Journey Medical (DERM) Finished Goods (2020 - 2021) Analysis & Trends

Journey Medical has reported Finished Goods for 2 years, with the latest figure at $4.3 million in Q4 2021.

  • For the quarter ending Q4 2021, Finished Goods rose 205.56% year-over-year to $4.3 million; the trailing twelve-month figure through Dec 2021 stood at $4.3 million (up 205.56% YoY), and the FY2021 full-year result was $4.3 million, up 205.56% from the prior year.
  • Finished Goods for Q4 2021 stood at $4.3 million, down from $6.2 million in the prior quarter.
  • The five-year high for Finished Goods was $6.2 million in Q3 2021, with the low at $1.4 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Journey Medical 168.75 Mn 141.53 Mn 9.70 Mn

Historic Data

Download Data
DateValue
Dec 31, 2021 4.29 Mn
Sep 30, 2021 6.16 Mn
Dec 31, 2020 1.40 Mn